FDC
Back to Balance Sheet
|
FDC Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹966 Cr | ₹812 Cr | ₹604 Cr | ₹469 Cr | ₹391 Cr |
What is the latest Total Non-Current Liabilities ratio of FDC ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹966 Cr |
| Mar2025 | ₹812 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹469 Cr |
| Mar2022 | ₹391 Cr |
How is Total Non-Current Liabilities of FDC Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹966 Cr | 18.96 | |
| Mar2025 | ₹812 Cr | 34.38 | |
| Mar2024 | ₹604 Cr | 28.92 | |
| Mar2023 | ₹469 Cr | 19.81 | |
| Mar2022 | ₹391 Cr | - | |
Compare Total Non-Current Liabilities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹6,166.1 Cr | -4% | 7.8% | -9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -4% |
7.8% |
-9% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses